Heart, Diabetes & Weight Loss Centers of New York Company Profile

22:20 EST 18th November 2017 | BioPortfolio

News Articles [4171 Associated News Articles listed on BioPortfolio]

Artificial Sweeteners Are Linked to Weight Gain—Not Weight Loss

A new analysis also links them to obesity, diabetes and heart disease

Weight gain may affect heart structure, increase risk for HF

Weight gain was associated with pathologic cardiac remodeling and an increased long-term risk for HF, according to new data from the Dallas Heart Study published in the Journal of the American Heart A...

Machine-learning techniques unlock benefit of weight loss for type 2 diabetes patients

Losing weight reduces the risk of long-term cardiovascular illness and mortality for the majority of patients with type 2 diabetes, but for a small subgroup, weight-loss intervention can lead to drama...

Machine-learning techniques used to unlock hidden benefit of weight loss interventions for overweight patients with type 2 diabetes

Losing weight reduces the risk of long-term cardiovascular illness and mortality for the majority of patients with type 2 diabetes, but for a small subgroup, weight-loss intervention can lead to drama...

Research Reveals AI Health Coaches As Effective as In-Person Professionals for Diabetes Prevention

New peer-reviewed findings published in JMIR Diabetes reveals that an artificial intelligence (AI) health coaches is just as effective as in-person weight loss programs, such as the Centers for Disea...

Group CBT Does Not Maintain Weight Loss in Obese With Diabetes

A randomized controlled trial in patients with both type 2 diabetes and obesity shows that cognitive behavior group therapy does not help maintain weight loss over 2 years. Medscape Medical News

Report suggests possible remission of type 2 diabetes through weight loss

Experts, in a report published in the BMJ yesterday suggest that for many patients type 2 diabetes could be reversed with a sustained weight loss of about 15 kg.

Steady Weight Loss Early Predicts Success

For people participating in a behavioral weight-loss program, weight variability during the first 6 to 12 weeks predicted worse weight-loss outcomes at 1 and 2 years, a study found. Medscape Medical...

PubMed Articles [7678 Associated PubMed Articles listed on BioPortfolio]

Medication use for the treatment of diabetes in obese individuals.

Obesity is a major cause of type 2 diabetes and may complicate type 1 diabetes. Weight loss for obese individuals with diabetes has many health benefits, often leads to improvement in glucose control ...

Preoperative Weight Loss With GLP-1 Receptor Agonist Treatment Predicts Greater Weight Loss Achieved by the Combination of Medical Weight Management And Bariatric Surgery In Patients With Type 2 Diabetes: A Longitudinal Analysis.

We examined the relationship between weight changes following preoperative glucagon-like peptide-1 receptor agonist (GLP-1 RA) and weight changes from the start of medical weight management (MWM) till...

Energy restriction and adherence required for weight loss without surgery Non-surgical weight loss treatment has not been shown to reduce mortality or cardiovascular morbidity, but can prevent diabete...

Evidence Base for Optimal Preoperative Preparation for Bariatric Surgery: Does Mandatory Weight Loss Make a Difference?

Preoperative weight loss regimens prior to bariatric surgery have been a routine and common practice for many centers, in the US and around the world. The mandated participation in such programs has l...

Cardiometabolic Disease Staging Predicts Effectiveness of Weight Loss Therapy to Prevent Type 2 Diabetes: Pooled Results From Phase III Clinical Trials Assessing Phentermine/Topiramate Extended Release.

To assess the ability of medication-assisted weight loss to prevent diabetes as a function of the baseline weighted Cardiometabolic Disease Staging (CMDS) score.

Clinical Trials [11995 Associated Clinical Trials listed on BioPortfolio]

PowerUp for Health: A Diabetes Prevention Program for Men

The purpose of this two-year proposal is to: 1. develop and 2. complete a pilot test of an adaptation of the evidence-based National Diabetes Prevention Program (NDPP) tai...

Diabetes Interventional Assessment of Slimming or Training to Lessen Inconspicuous Cardiovascular Dysfunction

There is an epidemic of type 2 diabetes in younger adults. These patients are at very high lifetime risk of heart-related complications. Subtle heart abnormalities can be present even at a...

Evaluating Weight Loss Programs for Obese People at Risk for Heart Disease (The POWER Study)

Many people who are obese also have high blood pressure, high cholesterol, or diabetes—all conditions that can increase the risk of heart disease. This study will evaluate two programs t...

Sleep Apnea in Look AHEAD (Action for Health in Diabetes)

This study will assess the effects of weight loss on sleep-disordered breathing (SDB) in 120 obese, type 2 diabetics with obstructive sleep apnea (OSA) from four Look AHEAD sites. Changes ...

BestFIT: a Personalized Weight Loss Program

The purpose of this study is to learn how to personalize weight loss programs. In this research we will study: 1. Whether a weight loss counselor should decide if the traditional weight...

Companies [3156 Associated Companies listed on BioPortfolio]

The Heart, Diabetes, and Weight Loss Centers of New York

Heart, Diabetes & Weight Loss Centers of New York

The Center for Medical Weight Loss

The Center for Medical Weight Loss markets and provides the first national network of medically supervised weight loss centers. The company's 300 centers, located in 43 states, offer customized we...

IntraPace, Inc.

IntraPace was founded in 2001 to address an unmet need in weight loss surgery by developing a gentler solution for weight loss that incorporates essential components of behavior t...

Thinique Medical Weight Loss

Founded in February 2013, Thinique Medical Weight Loss is a physician-supervised weight loss medical franchise that caters to men and women who want to lose weight and transition ...

More Information about "Heart, Diabetes & Weight Loss Centers of New York" on BioPortfolio

We have published hundreds of Heart, Diabetes & Weight Loss Centers of New York news stories on BioPortfolio along with dozens of Heart, Diabetes & Weight Loss Centers of New York Clinical Trials and PubMed Articles about Heart, Diabetes & Weight Loss Centers of New York for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Heart, Diabetes & Weight Loss Centers of New York Companies in our database. You can also find out about relevant Heart, Diabetes & Weight Loss Centers of New York Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record